Specialised blood product and cell-collection services.
Autologous, allogeneic, and haploidentical transplants for blood cancers and marrow failure.
Modern drugs that target cancer cells precisely while sparing healthy tissue.
Next-generation cell therapy for eligible myeloma and lymphoma patients.